BELITE BIO INC - AMERICAN DEPOSITARY SHARES

Belite Bio Receives Sakigake (Pioneer Drug) Designation of Tinlarebant for Stargardt Disease in Japan

12 يونيو 2024 01:55:28 بحسب Nasdaq GlobeNewswire

Belite Bio to Participate in the Benchmark’s 4th Annual Healthcare House Call Investor Conference

14 مايو 2024 07:00:00 بحسب Nasdaq GlobeNewswire

Belite Bio Reports First-Quarter 2024 Financial Results and Provides Corporate Update

13 مايو 2024 20:50:29 بحسب Nasdaq GlobeNewswire

Belite Bio to Participate in the H.C. Wainwright 2nd Annual BioConnect Investor Conference

13 مايو 2024 07:00:00 بحسب Nasdaq GlobeNewswire

Belite Bio to Host Webcast on May 14, 2024, to Discuss First Quarter 2024 Financial Results

08 مايو 2024 07:00:00 بحسب Nasdaq GlobeNewswire

Belite Bio to Participate in Key Opinion Leader Webinar to Discuss Unmet Needs In Stargardt Disease (STGD1) and Geographic Atrophy (GA) and Perspectives On Tinlarebant

06 مايو 2024 07:15:00 بحسب Nasdaq GlobeNewswire

Belite Bio Presents Additional Analysis from Phase 2 Study of Tinlarebant in Stargardt Disease at the ARVO Annual Meeting

06 مايو 2024 07:00:00 بحسب Nasdaq GlobeNewswire

Belite Bio Announces Presentation at the Association for Research in Vision and Ophthalmology 2024 Annual Meeting

01 مايو 2024 15:15:00 بحسب Nasdaq GlobeNewswire

Belite Bio Announces $25 Million Registered Direct Offering

25 أبريل 2024 18:15:29 بحسب Nasdaq GlobeNewswire

Belite Bio Announces PMDA Submission of Tinlarebant for Stargardt Disease Clinical Trial in Japan

22 مارس 2024 07:00:00 بحسب Nasdaq GlobeNewswire

Belite Bio Announces Availability of Annual Report on Form 20-F Through Company Website

11 مارس 2024 21:28:39 بحسب Nasdaq GlobeNewswire

Belite Bio Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update

11 مارس 2024 20:27:47 بحسب Nasdaq GlobeNewswire

Belite Bio to Host Webcast on March 12, 2024, to Discuss Fourth Quarter and Full Year 2024 Financial Results

06 مارس 2024 07:00:01 بحسب Nasdaq GlobeNewswire

Belite Bio to Participate in the Leerink Partners Global Biopharma Conference

04 مارس 2024 07:00:00 بحسب Nasdaq GlobeNewswire

Belite Bio to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference

07 فبراير 2024 07:00:00 بحسب Nasdaq GlobeNewswire

Belite Bio to Participate in the Benchmark Company’s Upcoming Discovery One-on-One Investor Conference

30 نوفمبر 2023 07:00:00 بحسب Nasdaq GlobeNewswire

Belite Bio to Participate in the BTIG Ophthalmology Day

20 نوفمبر 2023 07:00:00 بحسب Nasdaq GlobeNewswire

Belite Bio Reports Third Quarter 2023 Operational Highlights and Financial Results

13 نوفمبر 2023 19:15:47 بحسب Nasdaq GlobeNewswire

Belite Bio to Host Webcast on November 14, 2023, to Discuss Third Quarter 2023 Financial Results

07 نوفمبر 2023 07:00:00 بحسب Nasdaq GlobeNewswire

Belite Bio Presents Results from a 24-month, Phase 2 Study of Tinlarebant in Childhood-onset Stargardt Disease at the AAO Annual Meeting

06 نوفمبر 2023 07:00:00 بحسب Nasdaq GlobeNewswire